What Can We Expect From Long-Acting Formulations for Schizophrenia?

ArticleinCurrent Psychiatry Reports 13(4):243-4 · May 2011with7 Reads
Impact Factor: 3.24 · DOI: 10.1007/s11920-011-0206-2 · Source: PubMed